Poly Medicure Shareholder Divests Stake For Rs 443.82 Crore
Mumbai-based Lighthouse Advisors India through its affiliateLighthouse India III Equity Investorsoffloaded 22.76 lakh shares at Rs 1,950.03 apiece.21-06-2024
21-06-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
pursuant to Regulation 30(6) of SEBI(LODR) Regulations, 2015, we hereby submit transcript of the investor Meet/Call held on 20th May, 2024, on the Audited Financial Results of the Company for the quarter and year ended on 31st March , 2024, on standalone and consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 17th May, 2024.24-05-2024
POLY MEDICURE LTD. - 531768 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24(a) of SEBI (LODR) Regulations, 2015, we enclose herewith Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2024 by P.K. Mishra & Associates, Practising Company Secretaries.24-05-2024
Poly Medicure Q4 Results Review - Targeting Accelerated Growth: Systematix
Poly Medicure share of the overall disposable medical device pie in Europe is miniscule and there is very large headroom for them.21-05-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Monday, May 20, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended March 31, 2024 , is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/05/ICI3420240520153154.mp321-05-2024
Poly Medicure Results Earnings Call for Q4FY24
Conference Call with Poly Medicure Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.20-05-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Investor Presentation
Dear Sir, Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor''s Presentation with respect to Audited Financial Results for Quarter and Financial Year ended on March, 2024. The same is also available on the website of the Company i.e. www.polymedicure.com17-05-2024
POLY MEDICURE LTD. - 531768 - Compliance Of Regulation 30 (3)(D) Of SEBI (LODR) Regulations, 2015 Declaration Of Impact Of Un-Modified Audit Qualifications (Standalone & Consolidated)
In compliance of Regulation 33(3)(d) of SEBI(LODR) Regulations, 2015, we are here by declare that M/s. M.C. Bhandari & Co. statutory Auditors of the Company have issued audit report with unmodified opinion on the audited financial results(standalone and consolidated) for the forth quarter and financial year ended on 31st MARCH, 2024.17-05-2024
POLY MEDICURE LTD. - 531768 - Audited Financial Results (Consolidate & Standalone) For The Fourth Quarter And Financial Year Ended On 31St March 2024 Approved At Board Meeting Held Today I.E. 17Th May, 2024.
Pursuant to Regulatiom 30 and 33 of SEBI(LODR) Regulations, 2015, we are pleased to inform the stock exchange that the board of directors of at their meeting held today i.e. 17th May, 2024, at Crowne plaza today, plot No. 1, community centre, okhla -I, New Delhi 110020, approved the Audited Financial Results (Consolidated & Standalone) for the fourth quarter and financial year ended on 31st March, 2024.17-05-2024
POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 17th May, 2024, at Crowne Plaza Today, Plot No.1, Community Centre, Okhla -I, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate & Standalone) for the Fourth quarter and financial year ended on 31st March 2024. b. Recommendation of Dividend of Rs. 3 (Three Rupees) per Equity Shares (60%) of Rs. 5 each for the Financial Year 2023-24, subject to the approval of shareholders. c. Any Other Item. The Meeting was started at 10.30 am and concluded on 1:30 pm. Kindly take a note of the same for your further needful and oblige us.17-05-2024